Long pulse 532-nm laser treatment of facial telangiectasia.

Abstract

BACKGROUND:

Facial telangiectasias are a frequently observed cosmetic concern: Current therapeutic modalities have certain side effects and limitations. We treated a group of patients with facial telangiectasias with a new variable pulse width frequency-doubled neodymium: YAG laser at 532 nm.

OBJECTIVE:

This study evaluated the clinical response and side effects during the treatment of facial telangiectasias in 40 patients.

METHODS:

Forty patients with facial telangiectasias were treated with the VersaPulse laser. Fluences of between 9.5 and 12.0 J/cm2 at 3 or 4-mm spot size were used. A sapphire water-cooled chill tip was used to cool the cutaneous surface during treatment.

RESULTS:

Ninety percent of patients experienced between 75% and 100% clearance of their facial telangiectasias after single treatment. No significant side effects or complications were noted.

CONCLUSION:

The VersaPulse variable pulse width neodymium: YAG laser appears to be an effective treatment modality for facial telangiectasia.

• Authors: R M Adrian, E A Tanghetti
• Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 24 Issue 1 Pg. 71-4 (Jan 1998) ISSN: 1076-0512 [Print] United States
• PMID: 9464292 (Publication Type: Journal Article)

Topics

• Face (surgery)
• Humans
• Laser Therapy
• Skin (pathology)
• Telangiectasis (pathology, surgery)